4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-026183
Chief Financial Officer sold 20,000 shares at an average $41.30 ($826,005)
- Chief Financial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-04-06 | Option exercise | +10,000 | $6.32 | $63,200 | 31,604 | D |
| Cohen Chad M Chief Financial Officer | 2021-04-06 | Sale | −10,000 | $40.95 | $409,500 | 21,604 | D |
| Cohen Chad M Chief Financial Officer | 2021-04-07 | Option exercise | +10,000 | $6.32 | $63,200 | 31,604 | D |
| Cohen Chad M Chief Financial Officer | 2021-04-07 | Sale | −9,194 | $41.59 | $382,378 | 22,410 | D |
| Cohen Chad M Chief Financial Officer | 2021-04-07 | Sale | −806 | $42.34 | $34,126 | 21,604 | D |
| Derivatives | |||||||
| Cohen Chad M Chief Financial Officer | 2021-04-06 | Option exercise · Stock Option (Right to Buy) | −10,000 | 35,000 | D | ||
| Cohen Chad M Chief Financial Officer | 2021-04-07 | Option exercise · Stock Option (Right to Buy) | −10,000 | 25,000 | D | ||
| Open-market sales · 20,000 sh · avg $41.30 · $826,005 | |||||||
Loading xslF345X03/doc4.xml…